Cargando…

Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor

Beta-2 microglobulin is synthesized in all nucleated cells and forms the light chain subunit of the major histocompatibility complex class I antigen. Despite its potential role as a convenient and non-invasive prognostic indicator in malignant lymphomas, the influence of serum β2 microglobulin is cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Changhoon, Yoon, Dok Hyun, Suh, Cheolwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188779/ https://www.ncbi.nlm.nih.gov/pubmed/25325033 http://dx.doi.org/10.5045/br.2014.49.3.148

Ejemplares similares

Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era
por: Seo, Seyoung, et al.
Publicado: (2016)

Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma
por: Hyung, Jaewon, et al.
Publicado: (2019)

Prognostic Stratification of Patients with Burkitt Lymphoma Using Serum β2-microglobulin Levels
por: Kim, Hyung-Don, et al.
Publicado: (2021)

Relapse pattern and prognostic factors for patients with primary CNS lymphoma
por: Suh, Cheolwon, et al.
Publicado: (2012)

Relevance of prognostic index with β2-microglobulin for patients with diffuse large B-cell lymphoma in the rituximab era
por: Kang, Jihoon, et al.
Publicado: (2017)

Comparison of Serum Beta 2-Microglobulin and 24 hour Urinary Creatinine Clearance as a Prognostic Factor in Multiple Myeloma
por: Yun, Jae-Pil, et al.
Publicado: (2006)

Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology
por: Ahn, Yongchel, et al.
Publicado: (2017)

Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma
por: Hwang, Hee Sang, et al.
Publicado: (2013)

A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma: Incorporation of Serum β-2 Microglobulin to PINK
por: Kang, Sora, et al.
Publicado: (2023)

Modified Number of Extranodal Involved Sites as a Prognosticator in R-CHOP-Treated Patients with Disseminated Diffuse Large B-Cell Lymphoma
por: Yoo, Changhoon, et al.
Publicado: (2010)

Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
por: Johnson, P. W., et al.
Publicado: (1993)

GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma: Correlation with PD-L1 and PD-L2 Expression
por: Koh, Young Wha, et al.
Publicado: (2017)

Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
por: Child, J. A., et al.
Publicado: (1983)

Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era
por: Wang, Qin, et al.
Publicado: (2016)

Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma
por: Kim, Jeong Eun, et al.
Publicado: (2012)

Cluster Containing More Than 20 CD3-Positive Cells in Bone Marrow Biopsy Is a Candidate Prognostic Indicator in Peripheral T-Cell Lymphoma, Not Otherwise Specified
por: Shim, Hyoeun, et al.
Publicado: (2019)

The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
por: Cuzick, J., et al.
Publicado: (1985)

Intestinal Diffuse Large B-Cell Lymphoma: An Evaluation of Different Staging Systems
por: Hwang, Hee Sang, et al.
Publicado: (2014)

Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell Lymphoma in the Rituximab Era: A Single Institution Study
por: Hwang, Hee Sang, et al.
Publicado: (2021)

EBV-positive diffuse large B-cell lymphoma of the elderly with aberrant expression of CD3 and TIA-1
por: Lee, Miji, et al.
Publicado: (2013)

Clinical features and outcomes in patients with human immunodeficiency virus-negative, multicentric Castleman's disease: a single medical center experience
por: Seo, Seyoung, et al.
Publicado: (2014)

CD163 Expression Was Associated with Angiogenesis and Shortened Survival in Patients with Uniformly Treated Classical Hodgkin Lymphoma
por: Koh, Young Wha, et al.
Publicado: (2014)

The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis
por: Jiang, Tiantong, et al.
Publicado: (2016)

Case series of precursor B-cell lymphoblastic lymphoma
por: Kim, Jin Yong, et al.
Publicado: (2014)

Occurrence of sarcoidosis after chemotherapy for non-Hodgkin lymphoma
por: Cho, Hyungwoo, et al.
Publicado: (2016)

Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
por: Norfolk, D., et al.
Publicado: (1980)

Serum Beta-2 Microglobulin: A Possible Biomarker for Atrial Fibrillation
por: Zhang, Bangying, et al.
Publicado: (2021)

Breast implant–associated anaplastic large cell lymphoma: the first South Korean case
por: Lee, Jongwon, et al.
Publicado: (2020)

Factors Other than the Glomerular Filtration Rate That Determine the Serum Beta-2-Microglobulin Level
por: Stanga, Zeno, et al.
Publicado: (2013)

Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
por: Jang, Geundoo, et al.
Publicado: (2011)

Serum beta-2 microglobulin analysis in patients with oral squamous cell carcinoma
por: Sequeira, Joyce, et al.
Publicado: (2021)

Non-gastric Marginal Zone B-cell Lymphoma in Korea: Clinical Features, Treatment, and Prognostic Factors
por: Oh, Sung Yong, et al.
Publicado: (2010)

Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients
por: Jeong, Jae Ho, et al.
Publicado: (2017)

Increased urinary beta 2-microglobulin in cadmium exposure: dose-effect relationship and biological significance of beta 2-microglobulin.
por: Tsuchiya, K, et al.
Publicado: (1979)

B2 microglobulin is a novel prognostic marker of Angioimmunoblastic T-cell lymphoma
por: Shang, Yufeng, et al.
Publicado: (2018)

Primary mediastinal large B-cell lymphoma: a single-center experience in Korea
por: Ahn, Heui June, et al.
Publicado: (2014)

Expression of beta-2-microglobulin by nasopharyngeal carcinoma.
por: Shiu, W., et al.
Publicado: (1992)

Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution
por: Kim, Meejeong, et al.
Publicado: (2021)

A Case of Primary Adrenal Diffuse Large B-cell Lymphoma Achieving Complete Remission with Rituximab-CHOP Chemotherapy
por: Kim, Kyung Min, et al.
Publicado: (2009)

Serum beta2-microglobulin levels are highly associated with the risk of acute ischemic stroke
por: Qun, Sen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f8poeggeobdmtk4hu5tqechbj8